Holen Sie sich die Stockscreener-App
1.39
3.47%
-0.05
Schlusskurs vom Vortag:
$1.44
Offen:
$1.46
24-Stunden-Volumen:
17,194
Relative Volume:
0.01
Marktkapitalisierung:
$17.10M
Einnahmen:
$31.56M
Nettoeinkommen (Verlust:
$-46.89M
KGV:
-0.4583
EPS:
-3.0329
Netto-Cashflow:
$-26.70M
1W Leistung:
-14.20%
1M Leistung:
-24.86%
6M Leistung:
-28.72%
1J Leistung:
-76.87%
1-Tages-Spanne:
$1.37
$1.46
1-Wochen-Bereich:
$1.345
$1.73
52-Wochen-Spanne:
$1.0909
$6.30
Casi Pharmaceuticals Inc Stock (CASI) Company Profile
Firmenname
Casi Pharmaceuticals Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CASI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CASI
Casi Pharmaceuticals Inc
|
1.39 | 22.31M | 31.56M | -46.89M | -26.70M | -3.0329 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Casi Pharmaceuticals Inc Stock (CASI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-18 | Eingeleitet | BTIG Research | Buy |
| 2021-04-26 | Eingeleitet | Mizuho | Buy |
| 2020-10-23 | Eingeleitet | Oppenheimer | Outperform |
| 2016-09-22 | Eingeleitet | Maxim Group | Buy |
| 2015-10-29 | Fortgesetzt | H.C. Wainwright | Buy |
| 2015-06-23 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Casi Pharmaceuticals Inc Aktie (CASI) Neueste Nachrichten
Is CASI Pharmaceuticals Inc. stock a top momentum playQuarterly Earnings Summary & Weekly Return Optimization Alerts - newser.com
Is CASI Pharmaceuticals Inc. stock gaining market sharePortfolio Update Report & Long-Term Safe Investment Plans - newser.com
How to read the order book for CASI Pharmaceuticals Inc.2025 Big Picture & Precise Entry and Exit Recommendations - newser.com
Using data models to predict CASI Pharmaceuticals Inc. stock movementJuly 2025 Snapshot & AI Forecasted Stock Moves - newser.com
CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting - Corsicana Daily Sun
CASI Pharmaceuticals (NASDAQ: CASI) to present CID-103 ITP Phase 1 poster at ASH on Dec 7 - Stock Titan
What MACD and RSI say about CASI Pharmaceuticals Inc.Quarterly Earnings Summary & Free Accurate Trade Setup Notifications - newser.com
Can CASI Pharmaceuticals Inc. stock resist sector downturnsM&A Rumor & Safe Entry Point Identification - newser.com
Smart tools for monitoring CASI Pharmaceuticals Inc.’s price actionJuly 2025 Short Interest & Fast Moving Stock Watchlists - newser.com
How resilient is CASI Pharmaceuticals Inc. stock in market downturnsMarket Performance Report & Long-Term Capital Growth Ideas - newser.com
How CASI Pharmaceuticals Inc. stock performs in weak economyWeekly Earnings Recap & Expert Approved Trade Ideas - newser.com
Can CASI Pharmaceuticals Inc. stock deliver sustainable ROELayoff News & Real-Time Volume Analysis Alerts - newser.com
Will CASI Pharmaceuticals Inc. stock attract more institutional investorsJuly 2025 Reactions & Long-Term Growth Plans - newser.com
CASI Pharmaceuticals Forms Death Cross, Signaling Potential Bearish Trend - Markets Mojo
Is CASI Pharmaceuticals Inc. stock attractive for passive investorsMarket Activity Summary & Safe Entry Point Alerts - newser.com
CASI Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Anti-CD38 Antibody Clinical, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | I-MAB Biopharma, Takeda, HLX15, Ancora Biotech, CASI Pharmaceuticals - Barchart.com
Finanzdaten der Casi Pharmaceuticals Inc-Aktie (CASI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):